Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Regulatory News (CLL)

  • There is currently no data for CLL

Cello's Talking Taboos

19 Sep 2012 07:01

RNS Number : 5783M
Cello Group plc
19 September 2012
 



For Immediate Release

19 September 2012

 

Cello Group plc

("Cello", or "the Group")

 

 

Launch of Cello's Talking Taboos Results & Recommendations

 

Cello Group plc (AIM: CLL), the health focused insight and strategic marketing Group, is launching the results of its social responsibility programme 'Talking Taboos'.

 

Talking Taboos is a campaigning brand that aims to tackle health and social issues using Cello's experience and resources in the healthcare space. It will focus on areas where embarrassment, fear or ignorance prevents sufferers from seeking help.

 

On October 23 2012, Cello will reveal the results of a ground-breaking yearlong research study working in partnership with YoungMinds, the UK's leading children and young people's mental health and wellbeing charity. The research used a suite of services including advanced qualitative research, professional online community forums, social media discourse research integrated with a nationally representative quantitative sample of 2,500. It explores perceptions of young people who self-harm and whether they are receiving the help they so desperately need.

The study demonstrates Cello's expertise in the health sector and its commitment to stimulating discourse around pressing health and social issues. The Group has pooled its extensive knowledge and expertise with specific audiences, healthcare professionals, GP's, young people, teachers and parents to contribute to a 'whole community' view. In conjunction with YoungMinds, it will form the basis for a series of clear recommendations on how to relieve the suffering and distress experienced by those affected. Cello's communications team, led by Leith Group's Stripe Communications, will manage the media launch, targeting mainstream and health professional press as well as relevant online and social media channels. It will provide context for the growing national debate around self-harm and offer guidance and recommendations on how to better support those affected. The programme is being led by Vincent Nolan, Managing Partner of Cello Group and Founder of 2CV.

Mark Scott, Cello Group CEO, said:

 

"Talking Taboos is a great opportunity for us to show our ability to contribute to the wider social health debate by utilising our expertise in the Health sector and our market leading research and communications capabilities.

 

"It is also an ideal way for our companies to demonstrate their abilities and talents and work across the Group to deliver a comprehensive integrated project that will inform the way that self-harm is handled."

 

Enquiries:

 

Cello Group plc (www.cellogroup.com)

Mark Scott, Chief Executive

020 7812 8460

Vincent Nolan, Group Managing Partner

020 7655 9900

Cenkos

Bobbie Hilliam/Stephen Keys

020 7397 8900

Buchanan

Mark Edwards/Nicola Cronk/Clare Akhurst

020 7466 5000

 

 

 

Notes to Editors (www.cellogroup.com)

 

The launch event will be chaired by Claire Perry MP, at Portcullis House in the Houses of Parliament. For an invitation to the launch, or a copy of the report, contact talkingtaboos@stripecom.co.uk

About Cello

Cello is an insight and strategic marketing group.

The Group's strategy is to create value for shareholders by building an international marketing advisory business able to advise blue chip clients globally, with a primary focus on the pharmaceutical sector, along with other high margin client sectors.

Cello has annualised revenues in excess of £130m, annualised gross profit in excess of £65m and employs over 700 professional staff.

 

About YoungMinds

 

YoungMinds is the UK's leading charity committed to improving the emotional well-being and mental health of children and young people and empowering their parents and carers. Driven by their experiences we campaign, research and influence policy and practice. We also provide expert knowledge to professionals, parents and young people through our parents helpline, online resources, training and development, outreach work and publications. For further information visit www.youngminds.org.uk

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAFMGMLVRDGZZM
Date   Source Headline
5th Jun 20181:24 pmRNSBlock listing Interim Review
29th May 20183:45 pmRNSDirector/PDMR Dealings and Total Voting Rights
9th May 20181:14 pmRNSResult of AGM
9th May 20187:00 amRNSAGM Statement
30th Apr 20182:58 pmRNSTotal Voting Rights
26th Apr 20189:45 amRNSChange of Name
25th Apr 20184:45 pmRNSChange of Name update
23rd Apr 201810:28 amRNSChange of name to Cello Health Group plc
16th Apr 20189:30 amRNSAnnual Report and Notice of AGM
22nd Mar 20187:00 amRNSFinal Results
27th Feb 20183:38 pmRNSTotal Voting Rights
18th Jan 20187:00 amRNSPre Close Trading Statement
23rd Nov 20173:54 pmRNSHolding(s) in Company
31st Oct 201711:16 amRNSTotal Voting Rights
26th Oct 20172:37 pmRNSDirector/PDMR Shareholding
29th Sep 20173:43 pmRNSGrant of Options
27th Sep 20174:59 pmRNSDirector/PDMR Shareholding
22nd Sep 201712:05 pmRNSDirector/PDMR Shareholding
20th Sep 20173:58 pmRNSHolding(s) in Company
20th Sep 201711:52 amRNSAdditional Block Listing of Ordinary Shares
20th Sep 20177:00 amRNSInterim Results
31st Aug 20173:19 pmRNSTotal Voting Rights
31st Jul 20173:06 pmRNSTotal Voting Rights
19th Jul 20177:00 amRNSPre Close Trading Statement
18th Jul 20177:00 amRNSAcquisition of Advantage Healthcare Inc
30th Jun 201712:31 pmRNSTotal Voting Rights
23rd Jun 201712:23 pmRNSHolding(s) in Company
14th Jun 201711:33 amRNSDirector/PDMR Shareholding
31st May 201710:27 amRNSTotal Voting Rights
18th May 20172:13 pmRNSHolding(s) in Company
10th May 20175:18 pmRNSHolding(s) in Company
9th May 20172:55 pmRNSResult of AGM
9th May 20177:00 amRNSAGM Statement
2nd May 20173:15 pmRNSIssue of Equity
13th Apr 20172:40 pmRNSAnnual Report and notice of Annual General Meeting
4th Apr 20175:44 pmRNSBlock listing Interim Review
31st Mar 201710:43 amRNSTotal Voting Rights
28th Mar 20173:03 pmRNSHolding(s) in Company
22nd Mar 20177:00 amRNSPreliminary Results
21st Feb 20171:30 pmRNSHolding(s) in Company
20th Feb 20173:19 pmRNSHolding(s) in Company
20th Feb 20179:29 amRNSTotal Voting Rights
17th Feb 201710:40 amRNSResult of General Meeting
1st Feb 20177:00 amRNSPlacing & Acquisition of Defined Health
19th Jan 20177:00 amRNSPre close trading statement
31st Oct 20163:58 pmRNSTotal Voting Rights
28th Oct 201611:37 amRNSDirector/PDMR Shareholding
12th Oct 20167:00 amRNSDirectorate Change
5th Oct 20164:32 pmRNSDirector/PDMR Shareholding
23rd Sep 20165:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.